Item 5.07. Submission of Matters to a Vote of Security Holders




Following the Annual Meeting of the Stockholders of Natus Medical Incorporated
(the "Company") on June 15, 2022 (the "Annual Meeting"), Broadridge, the
Company's Transfer Agent, delivered its final vote tabulation on June 15, 2022
that certified the voting results for each of the matters set forth below that
were submitted to a vote at the Annual Meeting.

As of the close of business on April 18, 2022, the record date for the Annual
Meeting, 34,581,270 shares of the Company's common stock ("Common Stock"), were
outstanding and entitled to vote. 31,119,721 shares of Common Stock were voted
by proxy at the Annual Meeting, representing 89.99% of the shares entitled to
vote.

The final voting results for the Annual Meeting are as follows:

Proposal 1: Election of the following directors:



Nominee
                                      For                           Against                         Abstain                      Broker
                                                                                                                                Non-Votes
Ilan Daskal                       28,554,001                       1,370,377                        98,738                      1,096,605
Eric J. Guerin                    29,388,286                        528,020                         106,810                     1,096,605
Lisa Wipperman Heine              27,852,374                       2,064,032                        106,710                     1,096,605
Joshua H. Levine                  29,492,430                        423,003                         107,683                     1,096,605
Bryant M. Moore                   29,112,122                        804,182                         106,812                     1,096,605
Alice D. Schroeder                28,701,658                       1,223,695                        97,763                      1,096,605
Thomas J. Sullivan                29,603,809                        323,622                         95,685                      1,096,605


Proposal 2: Approval of Amended and Restated 2011 Employee Stock Purchase Plan.
                                        For                                Against                              Abstain                          Broker
                                                                                                                                                Non-Votes
                                    29,714,237                             191,187                              117,692                         1,096,605


Proposal 3: Advisory vote to approve the Company's Named Executive Officer compensation.
                                        For                                Against                               Abstain                             Broker
                                                                                                                                                    Non-Votes
                                     7,361,635                            22,365,583                             295,898                            1,096,605

Proposal 4: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm.


                                           For                                     Against                                   Abstain                                   Broker
                                                                                                                                                                      Non-Votes
                                       30,890,027                                  106,517                                   123,177

No other matters were considered or voted upon at the meeting.




Item 9.01.     Financial Statements and Exhibits


(d) Exhibits.

--------------------------------------------------------------------------------



  Exhibit No.            Description
                         The cover page from this Current Report on Form 8-K, formatted in Inline
104                      XBRL (included as Exhibit 101).

© Edgar Online, source Glimpses